These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21600635)

  • 21. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
    Rochet N; Sterzing F; Jensen AD; Dinkel J; Herfarth KK; Schubert K; Eichbaum MH; Schneeweiss A; Sohn C; Debus J; Harms W
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1382-9. PubMed ID: 19628341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
    Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
    In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Lim SS; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    Fertil Steril; 2010 Oct; 94(5):1812-6. PubMed ID: 20004371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of intraperitoneal chemotherapy in advanced epithelial ovarian cancer.
    Maheshwari A; Gupta S; Prabhash K; Tongaonkar HB
    Indian J Cancer; 2010; 47(2):225-6. PubMed ID: 20448394
    [No Abstract]   [Full Text] [Related]  

  • 26. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial.
    von Gruenigen VE; Courneya KS; Gibbons HE; Kavanagh MB; Waggoner SE; Lerner E
    Gynecol Oncol; 2008 Apr; 109(1):19-26. PubMed ID: 18243282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
    Schwartz PE; Rutherford TJ; Chambers JT; Kohorn EI; Thiel RP
    Gynecol Oncol; 1999 Jan; 72(1):93-9. PubMed ID: 9889037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE; Chambers JT; Makuch R
    Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian women's perspectives on ovarian cancer.
    Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
    Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
    Hartenbach EM; Harris LS; Bailey HH; Grosen EA; Larrison E; Chen D; Twiggs LB; Schink JC
    Cancer J Sci Am; 1999; 5(6):348-55. PubMed ID: 10606476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A telephone-delivered lifestyle intervention for colorectal cancer survivors 'CanChange': a pilot study.
    Hawkes AL; Gollschewski S; Lynch BM; Chambers S
    Psychooncology; 2009 Apr; 18(4):449-55. PubMed ID: 19241477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
    Curtin JP; Shapiro F
    Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients.
    Carmack Taylor CL; Demoor C; Smith MA; Dunn AL; Basen-Engquist K; Nielsen I; Pettaway C; Sellin R; Massey P; Gritz ER
    Psychooncology; 2006 Oct; 15(10):847-62. PubMed ID: 16447306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study.
    Hedelin M; Löf M; Andersson TM; Adlercreutz H; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):308-17. PubMed ID: 21098648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a 6-month lifestyle modification intervention on the cardiometabolic risk factors and health-related qualities of life in women with metabolic syndrome.
    Oh EG; Bang SY; Hyun SS; Kim SH; Chu SH; Jeon JY; Im JA; Lee MK; Lee JE
    Metabolism; 2010 Jul; 59(7):1035-43. PubMed ID: 20045151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer.
    Paulsen T; Kaern J; Kjaerheim K; Haldorsen T; Tropé C
    Gynecol Oncol; 2006 Sep; 102(3):447-52. PubMed ID: 16516277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
    Courneya KS; McKenzie DC; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; Segal RJ
    Cancer; 2008 Apr; 112(8):1845-53. PubMed ID: 18306372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experiences of Patients With Breast Cancer of Participating in a Lifestyle Intervention Study While Receiving Adjuvant Chemotherapy.
    Vassbakk-Brovold K; J Antonsen A; Berntsen S; Kersten C; Fegran L
    Cancer Nurs; 2018; 41(3):218-225. PubMed ID: 28221215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A complementary care study combining flaxseed oil, caffeine, fasting, and exercise in women diagnosed with advanced ovarian cancer: findings from a case study.
    Albrecht TA; Anderson JG; Jones R; Bourguignon C; Taylor AG
    Holist Nurs Pract; 2012; 26(6):308-16. PubMed ID: 23075747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.